Share:
Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies
VANCOUVER, BC, May 25, 2021 /CNW/ - Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe, is pleased to announce the chairs of its Clinical and Scientific Advisory Boards. The company welcomes Professor Jo Neill as the Chair of Albert Labs Clinical Advisory Board and Parminder Singh Chair of its Scientific Advisory Board. We are delighted to have such authority with Jo and Parminder, they bring a wealth of knowledge and expertise in each of their disciplines and we look forward to working with them in driving our Clinical and Scientific Advisory boards said Graeme McFarlane, Chief Commercial Officer of Albert Labs.
Adding to their Expert Team, Albert Labs Announces the Formation and Chairs of its Two Advisory Boards newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.